1. Home
  2. CTXR vs TIRX Comparison

CTXR vs TIRX Comparison

Compare CTXR & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • TIRX
  • Stock Information
  • Founded
  • CTXR 2007
  • TIRX 2010
  • Country
  • CTXR United States
  • TIRX China
  • Employees
  • CTXR N/A
  • TIRX N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • TIRX Specialty Insurers
  • Sector
  • CTXR Health Care
  • TIRX Finance
  • Exchange
  • CTXR Nasdaq
  • TIRX Nasdaq
  • Market Cap
  • CTXR 14.6M
  • TIRX 14.0M
  • IPO Year
  • CTXR N/A
  • TIRX 2021
  • Fundamental
  • Price
  • CTXR $1.58
  • TIRX $1.27
  • Analyst Decision
  • CTXR Strong Buy
  • TIRX
  • Analyst Count
  • CTXR 3
  • TIRX 0
  • Target Price
  • CTXR $53.00
  • TIRX N/A
  • AVG Volume (30 Days)
  • CTXR 6.8M
  • TIRX 1.2M
  • Earning Date
  • CTXR 08-11-2025
  • TIRX 08-15-2025
  • Dividend Yield
  • CTXR N/A
  • TIRX N/A
  • EPS Growth
  • CTXR N/A
  • TIRX N/A
  • EPS
  • CTXR N/A
  • TIRX N/A
  • Revenue
  • CTXR N/A
  • TIRX $3,219,336.00
  • Revenue This Year
  • CTXR N/A
  • TIRX N/A
  • Revenue Next Year
  • CTXR N/A
  • TIRX N/A
  • P/E Ratio
  • CTXR N/A
  • TIRX N/A
  • Revenue Growth
  • CTXR N/A
  • TIRX 158.74
  • 52 Week Low
  • CTXR $0.65
  • TIRX $1.07
  • 52 Week High
  • CTXR $26.25
  • TIRX $4.15
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 68.44
  • TIRX 42.99
  • Support Level
  • CTXR $0.76
  • TIRX $1.20
  • Resistance Level
  • CTXR $1.45
  • TIRX $1.45
  • Average True Range (ATR)
  • CTXR 0.31
  • TIRX 0.07
  • MACD
  • CTXR 0.06
  • TIRX -0.01
  • Stochastic Oscillator
  • CTXR 47.63
  • TIRX 29.63

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

Share on Social Networks: